SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRobert Walters Regulatory News (RWA)

Share Price Information for Robert Walters (RWA)

Share Price is delayed by 15 minutes
Get Live Data
85.00    1.00 (1.19%)
Bid:
84.00
Ask:
89.20
Spread: 5.20 (6.19%)
Market Cap: £55.91m
RWA Live PriceLast checked at - London Stock Exchange

Intraday Robert Walters Share Chart

Holding(s) in Company

15 Aug 2014 14:17

RNS Number : 2948P
Robert Walters PLC
15 August 2014
 



 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Robert Walters plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

Schroders plc

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

14.08.14

6. Date on which issuer notified:

15.08.14

7. Threshold(s) that is/are crossed orreached: vi, vii

11% - 10%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary

9,125,854

8,423,094

8,283,769

N/A

7,672,169

N/A

9.959%

GB0008475088

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

CFD

N/A

N/A

N/A

611,600

Nominal

Delta

0.794%

1

Total (A+B+C)

Number of voting rights

Percentage of voting rights

8,283,769

10.753%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Schroder Investment Management Limited 8,283,769 10.753%

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

The shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements. This disclosure has been calculated based on issue share capital amount 77,036,829.

14. Contact name:

 

Scott Dickenson

15. Contact telephone number:

 

020 7658 6000

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEADPSFFDLEFF
Date   Source Headline
14th May 20269:24 amRNSDirector/PDMR Shareholding
13th May 202610:40 amRNSDirector/PDMR Shareholding
5th May 202612:32 pmRNSDirector/PDMR Shareholding
1st May 202610:57 amRNSDirector/PDMR Shareholding
30th Apr 20263:16 pmRNSResult of AGM
30th Apr 202610:27 amRNSDirectorate change
28th Apr 202610:10 amRNSDirector/PDMR Shareholding
24th Apr 20269:34 amRNSDirector/PDMR Shareholding
17th Apr 20269:03 amRNSDirector/PDMR Shareholding
15th Apr 20267:00 amRNSQ1 2026 Trading Update
14th Apr 20265:35 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Apr 20263:46 pmRNSHolding(s) in Company
1st Apr 20266:12 pmRNSAnnual Financial Report
30th Mar 20267:00 amRNSBoard and Management Changes
27th Mar 20262:56 pmRNSHolding(s) in Company
27th Mar 20262:54 pmRNSHolding(s) in Company
23rd Mar 20269:21 amRNSHolding(s) in Company
17th Mar 202610:00 amRNSHolding(s) in Company
11th Mar 20267:00 amRNS2025 Full-Year Results
3rd Feb 20264:08 pmRNSHolding(s) in Company
15th Jan 20267:00 amRNSQ4 2025 Trading Update
18th Dec 20257:00 amRNSAppointment of Non-Executive Director
18th Nov 20255:10 pmRNSHolding(s) in Company
17th Nov 20255:00 pmRNSHolding(s) in Company
6th Nov 20258:55 amRNSBLOCK LISTING SIX-MONTHLY RETURN
14th Oct 20257:00 amRNSQ3 2025 Trading Update
11th Sep 20253:06 pmRNSHolding(s) in Company
8th Aug 20252:33 pmRNSHolding(s) in Company
31st Jul 20257:00 amRNS2025 Half-Year Results
23rd Jul 20254:56 pmRNSHolding(s) in Company
23rd Jul 20254:54 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSQ2 2025 Trading Update
9th Jun 20252:11 pmRNSHolding(s) in Company
4th Jun 20253:49 pmRNSHolding(s) in Company
2nd Jun 20252:50 pmRNSHolding(s) in Company
30th Apr 20254:09 pmRNSHolding(s) in Company
29th Apr 20252:59 pmRNSResult of 2025 Annual General Meeting
16th Apr 202512:06 pmRNSDirector/PDMR Shareholding
15th Apr 20257:00 amRNSQ1 2025 Trading Update
28th Mar 202511:00 amRNSAnnual Report and Annual General Meeting
12th Mar 202511:47 amRNSDirector/PDMR Shareholding
7th Mar 20259:28 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNS2024 full-year results
14th Feb 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSHolding(s) in Company
14th Jan 20257:00 amRNSQ4 2024 Trading Update
10th Jan 20254:22 pmRNSHolding(s) in Company
17th Dec 20244:32 pmRNSHolding(s) in Company
13th Dec 202411:06 amRNSHolding(s) in Company
11th Dec 20247:00 amRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.